Commentary on the Paper of Walther L. et al.: Phosphatidylethanol Is Superior to CDT and GGT as an Alcohol Marker and Is a Reliable Estimate of Alcohol Consumption Level

Alcoholism: Clinical and Experimental Research

Volumn 40, Issue 2, 2016, Pages 260-262

  Weinmann, Wolfgang ^a   Schröck, Alexandra ^a   Wurst, Friedrich M ^b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; PHOSPHATIDYLETHANOL; PHOSPHOLIPID; UNCLASSIFIED DRUG; GLYCEROPHOSPHOLIPID; TRANSFERRIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MEDICAL AUDIT; NATIONAL HEALTH ORGANIZATION; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; BLOOD; DRINKING BEHAVIOR; FEMALE; MALE;

ALCOHOL DRINKING; ALCOHOLISM; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLYCEROPHOSPHOLIPIDS; HUMANS; MALE; TRANSFERRIN;

EID: 84956891339     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12946     Document Type: Article

References (17)

1. Alling C, Gustavsson L, Änggård E (1983) An abnormal phospholipid in rat organs after ethanol. FEBS Lett 152:24-28.
2. Gnann H, Thierauf A, Hagenbuch F, Röhr B, Weinmann W (2014) Time dependence of elimination of different PEth homologues in alcoholics in comparison with social drinkers. Alcohol Clin Exp Res 38:322-326.
3. Gnann H, Weinmann W, Thierauf A (2012) Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Alcohol Clin Exp Res 36:1507-1511.
4. Haber P, Lintzeris N, Proude E, Lopatko O (2009) Guidelines for the Treatment of Alcohol Problems. Australian Government Department of Health and Ageing, Sydney, NSW.
5. Helander A, Hansson T (2013) [National harmonization of the alcohol biomarker PEth]. Läkartidningen 110:1747-1748.
6. Jackson R, Johnson M, Campbell F, Messina J, Guillaume L, Meier P, Goyder E, Chilcott J, Payne N (2010) Screening and Brief Interventions for Prevention and Early Identification of Alcohol Use Disorders in Adults and Young People. University of Sheffield, School of Health and Related Research (ScHARR) Public Health Collaborating Centre, Sheffield.
7. Mann K, Hoch E, Batra A, on behalf of the guideline working group (2015) S3-Leitlinie "Screening, diagnose und Behandlung alkoholbezogener Störungen" [S3 Guideline "Screening, diagnosis and treatment of alcohol use disorders"]. AWMF, Register Nr. 076-001. Available at: http://www.awmf.org/uploads/tx_szleitlinien/076-001l_S3-Leitlinie_Alkohol_2015-04.pdf. Accessed October 13, 2015.
8. National Institute for Health and Clinical Excellence (NICE) (2011) Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence (CG 115). National Institute for Health and Clinical Excellence. Available at: https://www.nice.org.uk/guidance/cg115. Accessed November 17, 2015.
9. National Institute on Alcohol Abuse and Alcoholism (2015) Drinking levels defined. Available at: http://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed October 20, 2015.
10. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction 88:791-804.
11. Schröck A, Bütikofer P, Weinmann W (2015) Development of a standardized test for the activity of the enzyme phospholipase D (PL D) responsible for biosynthesis of the alcohol biomarker phosphatidylethanol (PEth). Oral presentation at the 53nd Annual Meeting of the International Association of Forensic Toxicology (TIAFT), Florence, Italy, August 30-September 4.
12. Schröck A, Thierauf A, Weinmann W (2014) Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol-a drinking study with 16 volunteers. Oral presentation at the 52nd Annual Meeting of the International Association of Forensic Toxicology (TIAFT), Buenos Aires, Argentina, November 9-November 13.
13. Varga A, Hansson P, Johnson G, Alling C (2000) Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 299:141-150.
14. Walther L, de Bejczy A, Löf E, Hansson T, Andersson A, Guterstam J, Hammarberg A, Asanovska G, Franck J, Söderpalm B, Isaksson A (2015) Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level. Alcohol Clin Exp Res 39:2200-2208.
15. World Health Organization (2000) International guide for monitoring alcohol consumption and related harm. Available at: http://apps.who.int/iris/handle/10665/66529. Accessed October 20, 2015.
16. Wurst FM, Thon N, Yegles M, Schröck A, Preuss UW, Weinmann W (2015) Ethanol metabolites: their role in the assessment of alcohol intake. Alcohol Clin Exp Res 39:2060-2072.
17. Zheng Y, Beck O, Helander A (2011) Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood. Clin Chim Acta 412:1428-1435.